Friday, 16 October 2026European Markets

VOW Stock Jumps By 30% In The Last 21 Sessions

Loading stream...

Vow ASA (VOW.OL), a listed company on Oslo Bors Benchmark Index, has exhibited a stunning performance lately. A remarkable 30.54% gain over 21 sessions on this Index has seen the company's standing rise from kr12.9 to 16.84, an extraordinary achievement indeed. This commendable growth is set within the backdrop of an overall increase in the index, which has seen an increase of 0.83% to 1,242.79.

Current Position of VOW

VOW recently closed at kr16.82, which is 38.3% below its 52-week peak of kr27.26. Given its significant rise in recent times, one might infer that there are opportunities for further growth in the upcoming months, provided VOW manages to sustain its momentum.

The Business Model

Vow ASA's operating model involves offering solutions for processing and purifying various genres of waste across different international markets. Its diverse portfolio encapsulates segments for Projects Cruise, Aftersales, Landbased, and Aftercare services. This allows the company to adapt to changing market trends and demands efficiently.

Performance and Profitability

Despite being in operation for only a short duration, VOW has had a moderate run of success. Earning per share (EPS) stands at kr0.12, and it currently trades with a price-to-earnings ratio (P/E) ratio of 140.33. This suggests that investors may be inclined to pay a greater price for its shares, spurred by the hope of future expansion. However, the company's return on equity is only 2.73%, indicating below-average profitability concerning shareholder's equity.

Revenue Increase and the Fluctuations

Over the past year, VOW has demonstrated considerable growth abilities, recording a 51.5% incremental increase in quarter-by-quarter annual revenue, amounting to a total of 782.8M across four quarters. While these indicators point to positive prospects for VOW stock, the company's volatility has also been noteworthy. The average intraday variation for VOW over the past week, month, and quarter has swung between -0.72%, +1.02% and +3.16% respectively. This underscores the speed at which its price can vary, presenting opportunities for investors to accrue substantial gains or losses within short periods.

A Word of Caution for Investors

Stock investments inherently carry risk; however, VOW has showcased potential with impressive revenue growth and a bullish trend. Investors are best advised to proceed cautiously, particularly in light of the company's high P/E ratio. Thorough research is paramount before making any investment decisions.

More news about VOW (VOW.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com